|
1
|
Mehta PS and Harrison LB: Function and
organ preservation in adult cancers of the head and neck. Expert
Rev Anticancer Ther. 7:361–371. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vokes EE: Induction chemotherapy for head
and neck cancer: recent data. Oncologist. 15(Suppl 3): 3–7. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shukla S, Wu CP and Ambudkar SV:
Development of inhibitors of ATP-binding cassette drug
transporters: present status and challenges. Expert Opin Drug Metab
Toxicol. 4:205–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neyns B, Tosoni A, Hwu WJ and Reardon DA:
Dose-dense temozolomide regimens: antitumor activity, toxicity, and
immunomodulatory effects. Cancer. 116:2868–2877. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baguley BC: Multiple drug resistance
mechanisms in cancer. Mol Biotechnol. 46:308–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Connor R: The pharmacology of cancer
resistance. Anticancer Res. 27:1267–1272. 2007.
|
|
7
|
Kruse AL and Grätz KW: Oral carcinoma
after hematopoietic stem cell transplantation - a new
classification based on a literature review over 30 years. Head
Neck Oncol. 1:292009.PubMed/NCBI
|
|
8
|
Longley DB and Johnston PG: Molecular
mechanisms of drug resistance. J Pathol. 205:275–292. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dizdarevic S and Peters AM: Imaging of
multidrug resistance in cancer. Cancer Imaging. 11:1–8. 2011.
View Article : Google Scholar
|
|
10
|
Vasiliou V, Vasiliou K and Nebert DW:
Human ATP-binding cassette (ABC) transporter family. Hum Genomics.
3:281–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cianfriglia M, Cenciarelli C, Barca S,
Tombesi M, Flego M and Dupuis ML: Monoclonal antibodies as a tool
for structure-function studies of the MDR1-P-glycoprotein. Curr
Protein Pept Sci. 3:513–530. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van den Heuvel-Eibrink MM, van der Holt B,
Burnett AK, et al: CD34-related coexpression of MDR1 and BCRP
indicates a clinically resistant phenotype in patients with acute
myeloid leukemia (AML) of older age. Ann Hematol. 86:329–337.
2007.PubMed/NCBI
|
|
13
|
Kuo MT: Roles of multidrug resistance
genes in breast cancer chemoresistance. Adv Exp Med Biol.
608:23–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu K, Chen L, Han X and Wang J and Wang
J: Short hairpin RNA targeting Twist1 suppresses cell proliferation
and improves chemosensitivity to cisplatin in HeLa human cervical
cancer cells. Oncol Rep. 27:1027–1034. 2012.PubMed/NCBI
|
|
15
|
Qin Q, Xu Y, He T, Qin C and Xu J: Normal
and disease-related biological functions of Twist1 and underlying
molecular mechanisms. Cell Res. 22:90–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhan X, Feng X, Kong Y, Chen Y and Tan W:
JNK signaling maintains the mesenchymal properties of multi-drug
resistant human epidermoid carcinoma KB cells through snail and
twist1. BMC Cancer. 13:1802013. View Article : Google Scholar
|
|
17
|
Ma J, Lu S, Yu L, et al: FaDu cell
characteristics induced by multidrug resistance. Oncol Rep.
26:1189–1195. 2011.PubMed/NCBI
|
|
18
|
Liang Y, Meleady P, Cleary I, McDonnell S,
Connolly L and Clynes M: Selection with melphalan or paclitaxel
(Taxol) yields variants with different patterns of multidrug
resistance, integrin expression and in vitro invasiveness. Eur J
Cancer. 37:1041–1052. 2001. View Article : Google Scholar
|
|
19
|
Laborde E: Glutathione transferases as
mediators of signaling pathways involved in cell proliferation and
cell death. Cell Death Differ. 17:1373–1380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu L, Li HZ, Lu SM, et al: Alteration in
TWIST expression: possible role in paclitaxel-induced apoptosis in
human laryngeal carcinoma Hep-2 cell line. Croat Med J. 50:536–542.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lemma S, Karihtala P, Haapasaari KM, et
al: Biological roles and prognostic values of the
epithelial-mesenchymal transition-mediating transcription factors
Twist, ZEB1 and Slug in diffuse large B-cell lymphoma.
Histopathology. 62:326–333. 2013. View Article : Google Scholar
|
|
22
|
Banerjee A, Qian P, Wu ZS, et al: Artemin
stimulates radio- and chemo-resistance by promoting
TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary
carcinoma cells. J Biol Chem. 287:42502–42515. 2012. View Article : Google Scholar
|
|
23
|
Zhuo WL, Wang Y, Zhuo XL, Zhang YS and
Chen ZT: Short interfering RNA directed against TWIST, a novel zinc
finger transcription factor, increases A549 cell sensitivity to
cisplatin via MAPK/mitochondrial pathway. Biochem Biophys Res
Commun. 369:1098–1102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li L, Jiang AC, Dong P, Wang H, Xu W and
Xu C: MDR1/P-gp and VEGF synergistically enhance the invasion of
Hep-2 cells with multidrug resistance induced by taxol. Ann Surg
Oncol. 16:1421–1428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saxena M, Stephens MA, Pathak H and
Rangarajan A: Transcription factors that mediate
epithelial-mesenchymal transition lead to multidrug resistance by
upregulating ABC transporters. Cell Death Dis. 2:e1792011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wallerand H, Robert G, Pasticier G, et al:
The epithelial-mesenchymal transition-inducing factor TWIST is an
attractive target in advanced and/or metastatic bladder and
prostate cancers. Urol Oncol. 28:473–479. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piotrowska H, Kucinska M and Murias M:
Biological activity of piceatannol: leaving the shadow of
resveratrol. Mutat Res. 750:60–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wyllie AH: “Where, O death, is thy sting?”
A brief review of apoptosis biology. Mol Neurobiol. 42:4–9.
2010.
|
|
29
|
Tomiyama A, Tachibana K, Suzuki K, et al:
MEK-ERK-dependent multiple caspase activation by mitochondrial
proapoptotic Bcl-2 family proteins is essential for heavy ion
irradiation-induced glioma cell death. Cell Death Dis. 1:e602010.
View Article : Google Scholar
|
|
30
|
Qin H, Srinivasula SM, Wu G,
Fernandes-Alnemri T, Alnemri ES and Shi Y: Structural basis of
procaspase-9 recruitment by the apoptotic protease-activating
factor 1. Nature. 399:549–557. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shang L, Liu J, Zhu Q, et al: Gypenosides
protect primary cultures of rat cortical cells against oxidative
neurotoxicity. Brain Res. 1102:163–174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang JQ, Chen Q, Wang X, et al:
Dysregulation of mitochondrial calcium signaling and superoxide
flashes cause mitochondrial genomic DNA damage in Huntington
disease. J Biol Chem. 288:3070–3084. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Demirci S, Kutluhan S, Naziroğlu M, Uğuz
AC, Yürekli VA and Demirci K: Effects of selenium and topiramate on
cytosolic Ca(2+) influx and oxidative stress in neuronal PC12
cells. Neurochem Res. 38:90–97. 2013.PubMed/NCBI
|
|
34
|
Naziroglu M: Molecular role of catalase on
oxidative stress-induced Ca(2+) signaling and TRP cation channel
activation in nervous system. J Recept Signal Transduct Res.
32:134–141. 2012.
|
|
35
|
Zhang X, Wang Q, Ling MT, Wong YC, Leung
SC and Wang X: Anti-apoptotic role of TWIST and its association
with Akt pathway in mediating taxol resistance in nasopharyngeal
carcinoma cells. Int J Cancer. 120:1891–1898. 2007. View Article : Google Scholar : PubMed/NCBI
|
